The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma

被引:91
作者
Huang, GW
Sunagawa, M
Li, JE
Shimada, S
Gang, Z
Tokeshi, Y
Kosugi, T
机构
[1] Univ Ryukyus, Sch Med, Dept Physiol 1, Nishihara, Okinawa 9030215, Japan
[2] Guangxi Univ Tradit Chinese Med, Dept Otorhinolaryngol, Nanning 530021, Guangxi, Peoples R China
关键词
nasopharyngeal carcinoma; vascular endothelial growth factor; angiogenesis; tumor metastasis;
D O I
10.1097/00005537-200012000-00017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: The present study was aimed at clarifying whether the microvessel density (MVD) and the expression of vascular endothelial growth factor (VEGF) were related to the degree of local invasion and metastasis in nasopharyngeal carcinoma (NPC), Study Design: We measured the MVD and examined whether VEGF was expressed in NPC tissue using histological study combined with immunohistochemistry, Methods: MVD and VEGF expression was measured in 73 specimens of NPC, 15 benign tumors of nasopharyngeal region, and 20 nasopharyngeal tissue without tumor. MVD and VEGF expression in NPC was compared between a metastasis group (49 specimens) and a non-metastasis group (24 specimens). Results: Both MVD and VEGF expression were markedly increased in NPC tissue as compared with those in benign tumors of nasopharyngeal region. Both MVD and VEGF expression in NPC tissue with metastasis mere statistically significantly increased as compared with those in NPC without metastasis, Therefore, the invasion and metastasis of NPC cells were closely related to MVD and the expression of VEGF in NPC tissue. Conclusion: The metastatic potency of NPC tissue and the prognosis of the patients with NPC can be estimated by measuring MVD and the expression of VEGF in NPC tissue. Drugs that have inhibitory actions on angiogenesis could be useful to prevent metastasis of NPC cells in the patients.
引用
收藏
页码:2066 / 2069
页数:4
相关论文
共 26 条
[1]   Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer [J].
Anan, K ;
Morisaki, T ;
Katano, M ;
Ikubo, A ;
Kitsuki, H ;
Uchiyama, A ;
Kuroki, S ;
Tanaka, M ;
Torisu, M .
SURGERY, 1996, 119 (03) :333-339
[2]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[3]  
Burian M, 1999, ACTA OTO-LARYNGOL, V119, P289
[4]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[5]   ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS [J].
FOLKMAN, J ;
MERLER, E ;
ABERNATHY, C ;
WILLIAMS, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (02) :275-+
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]  
FOLKMAN J, 1974, CANCER RES, V34, P2109
[8]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[9]   Platelet aggregation in head and neck tumors in China [J].
Huang, GW ;
Nong, HT ;
Yu, QS ;
Kinjoh, K ;
Nakamura, M ;
Kosugi, T .
LARYNGOSCOPE, 1997, 107 (08) :1142-1145
[10]   VASCULAR-PERMEABILITY FACTOR, AN ENDOTHELIAL-CELL MITOGEN RELATED TO PDGF [J].
KECK, PJ ;
HAUSER, SD ;
KRIVI, G ;
SANZO, K ;
WARREN, T ;
FEDER, J ;
CONNOLLY, DT .
SCIENCE, 1989, 246 (4935) :1309-1312